Outspoken Oncology

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, makes her sixth appearance on the show to discuss practical considerations for "ramp-up" testing, what a negative test result really means (or does not mean) and how often to repeat the test, updates on data for remdesivir, and more.

Adam Feuerstein, national biotech columnist, STAT, provides a look into the complexity of reporting on biotech and health care advancements, the shift in STAT's editorial focus to COVID-19 coverage from a science and biotech perspective, and other topics.

Adam Feuerstein, national biotech columnist, STAT, provides a look into the complexity of reporting on biotech and health care advancements, the shift in STAT's editorial focus to COVID-19 coverage from a science and biotech perspective, and other topics.

Michael Sinha, MD, JD, MPH, research fellow, Harvard-MIT Center for Regulatory Science, dissects the legality of international and domestic travel bans from a health policy perspective, the nuances of state-level authority to enforce a lockdown, the rights of health care workers to refuse reporting to work in the absence of ample and appropriate PPEs, and more.

Michael Sinha, MD, JD, MPH, research fellow, Harvard-MIT Center for Regulatory Science, dissects the legality of international and domestic travel bans from a health policy perspective, the nuances of state-level authority to enforce a lockdown, the rights of health care workers to refuse reporting to work in the absence of ample and appropriate PPEs, and more.

Seth Trueger, MD, MPH, FACEP, emergency physician at Northwestern University, shares the steps taken in an emergency room setting to prepare for an influx of patients, screening processes for patient admissions, triage steps for patients who arrive at the door, and concerns of misdiagnoses, among other topics.

Seth Trueger, MD, MPH, FACEP, emergency physician at Northwestern University, shares the steps taken in an emergency room setting to prepare for an influx of patients, screening processes for patient admissions, triage steps for patients who arrive at the door, and concerns of misdiagnoses, among other topics.

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, returns to discuss crucial considerations for reopening the country, reactions to the way infection control experts have handled new information, and the overreaction to a recent preliminary report from the University of Chicago on a potential treatment option.

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, returns to discuss crucial considerations for reopening the country, reactions to the way infection control experts have handled new information, and the overreaction to a recent preliminary report from the University of Chicago on a potential treatment option.

Vincent Rajkumar, MD, and Rafael Fonseca, MD, both multiple myeloma specialists at Mayo Clinic, discuss the prospect of opening the country before a vaccine is developed for COVID-19; whether the decisions should be made on a county-, state-, or regional-level; and the critical need for a "TTP" approach: widespread adequate Testing, contact Tracing, and PPEs.